Article Per Year (5 Year)
p-Index From 2021 - 2026
1.704
P-Index
This Author published in this journals
All Journal Jurnal Akuntansi & Auditing Indonesia Journal of Indonesian Economy and Business Research In Management and Accounting (RIMA) JAAF (Journal of Applied Accounting and Finance) Perspektif Akuntansi Proceeding of the International Conference on Family Business and Entrepreneurship (ICFBF) International Journal of Applied Business and International Management Journal of Practical Management Studies Atestasi : Jurnal Ilmiah Akuntansi Research In Management and Accounting (RIMA)
Andrianantenaina, Hajanirina
President University
Humanities Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Education Social Sciences Other

Published : 20 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Journal of Practical Management Studies

 1 
Board Size and Leverage in Indonesian’s Pharmaceutical Companies. The Moderating Role of Profitability Sanga, Marianus Hendrilensio; Hajanirina, Andrianantenaina
Journal of Practical Management Studies Vol. 1 No. 2 (2023): Vol. 1 No. 2 (2023): JPMS - September
Publisher : CV. Jala Berkat Abadi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61106/jpms.v1i2.9

Abstract

This empirical study examines the relationship between board size, leverage, and profitability in the pharmaceutical sector. Using a sample of pharmaceutical companies from 2019 to 2022, the study reveals that board size has a significant positive impact on leverage. Additionally, profitability acts as a moderator in the relationship between board size and leverage. The results indicate a significant negative relationship between board size and leverage when considering profitability, suggesting that larger boards in pharmaceutical companies are associated with lower levels of leverage. These findings contribute to the existing literature on corporate governance and financial performance, highlighting the significance of board size in shaping leverage decisions and influencing profitability. The study suggests that larger boards in the pharmaceutical sector exercise caution in managing debt, leveraging their enhanced monitoring capabilities, diverse expertise, and increased accountability. Policymakers, industry practitioners, and investors can use these insights to make informed decisions regarding board composition, financing strategies, and evaluating the financial performance and risk profiles of pharmaceutical companies.
Co-Authors Adhi Setyo Santoso Andi Ina Yustina Aritonang, Elisha Princess Christin Natalia Benyadi Farah Chintya Farah Chintya Benyadi Gatot Imam Nugroho Ika Pratiwi Simbolon Maria Ferentina Owena Marianus Hendrilensio Sanga Mila Austria Reyes Mila Austria Reyes Muhammad Ilham Prasetyo Sitorus Nitiwijaya, Yoyo Sunaryo Nugaha, Bima Aditya Purwaningsih . Reyes, Mila Austria Rofian Almas Akbar Silalahi, Santa Grace Meybiola Tan, Thalia Margareta Wang Gen Yoyo Sunaryo Nitiwijaya Yustina, Andi Ina